凯胺通过细胞类型和输入特定适应在核中拯救了安赫多尼亚
bioRxiv : the preprint server for biology
|June 19, 2023
概括
胺素通过恢复核聚合体 (NAc) 中的突触强度,迅速缓解无情感,这是一个核心抑郁症症状. 这项研究确定了胺胺必不可少的特定神经回路.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 分子生物学分子生物学
背景情况:
- 无情是抑郁症的核心症状,显著影响生活质量.
- 胺显示出快速和持续的抗抑郁作用,特别是在治疗耐药抑郁症中.
- 基胺的持续治疗效果背后的精确神经机制,特别是对安赫多尼亚的治疗效果,仍然不清楚.
研究的目的:
- 为了研究核 (NAc) 在胺胺对无情感的抗抑郁作用中的作用.
- 为了确定特定的突触变化和神经回路,涉及到胺的持续作用.
- 探索NAc中的细胞类型特异性适应和输入特异性可塑性,这些可塑性介导着胺的治疗效益.
主要方法:
- 利用老鼠模型的慢性压力诱导的无情感.
- 采用一种新的细胞特异性药理方法,准NAc中的表达D1多巴胺受体的中等棘状神经元 (D1-MSNs).
- 应用光遗传和化学遗传技术来研究突触前输入和突触可塑性.
主要成果:
- 胺可以通过恢复NAc D1-MSN的激发性突触强度来挽救压力诱导的.
- 在D1-MSNs中,细胞类型特异性神经适应被证明是持续胺效应所必需的.
- 在D1-MSN中模仿胺诱导的突触可塑性重新总结了行为改善.
- 发现胺可以逆转压力诱导的激发力在中部前额叶皮质和腹部海马体输入NAc D1-MSN的刺激强度的减少.
- 在NAc中,输入特定可塑性被确定为胺对快乐行为控制的关键机制.
结论:
- 核对于胺胺对无情感的抗抑郁作用至关重要.
- 在NAc中胺诱导的细胞类型特异性突触适应对于其持续的治疗疗效至关重要.
- 胺通过调节NAc D1-MSN的特定谷氨基基输入来发挥其作用,从而控制享乐行为.
相关概念视频
Parenteral Anesthetics: Overview
162
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
162
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
209
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
209
Drugs Affecting Neurotransmitter Release or Uptake
1.1K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.1K
Adrenergic Agonists: Indirect-Acting Agents
1.7K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.7K
Antidepressant Drugs: MAOIs and Other Agents
280
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
280
Sedatives and Hypnotics Drugs: Miscellaneous Agents
205
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
205


